Profound Medical Corp. (TSX:PRN)
Canada · Delayed Price · Currency is CAD 9.69
-0.03 (-0.31%)
Aug 13, 2026, 10:47 AM EST
Profound Medical Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Profound Medical stock have an average target of $21.50, which predicts a 121.88% increase from the current stock price of 9.69.
Price Target: $21.50 (+121.88%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Profound Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $13.93 | Buy | Maintains | $13.93 | +43.76% | Aug 7, 2026 |
| Lake Street | Lake Street | Buy Reiterates $16.72 | Buy | Reiterates | $16.72 | +72.51% | Aug 7, 2026 |
| Raymond James | Raymond James | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 7, 2026 |
Financial Forecast
Revenue This Year
26.41M
from 16.10M
Increased by 64.06%
Revenue Next Year
43.36M
from 26.41M
Increased by 64.17%
EPS This Year
-0.87
from -1.41
EPS Next Year
-0.60
from -0.87
EPS and Forward PE are based on non-GAAP adjusted numbers.